Next Article in Journal
The Evolution of Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Next Article in Special Issue
Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study
Previous Article in Journal
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future—Five-Years’ Single-Institution Experience of 762 Consecutive Patients
Previous Article in Special Issue
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer
 
 
Article

Article Versions Notes

Cancers 2022, 14(7), 1639; https://doi.org/10.3390/cancers14071639
Action Date Notes Link
article pdf uploaded. 23 March 2022 17:44 CET Version of Record https://www.mdpi.com/2072-6694/14/7/1639/pdf-vor
article xml file uploaded 28 March 2022 12:48 CEST Original file -
article xml uploaded. 28 March 2022 12:48 CEST Update https://www.mdpi.com/2072-6694/14/7/1639/xml
article pdf uploaded. 28 March 2022 12:48 CEST Updated version of record https://www.mdpi.com/2072-6694/14/7/1639/pdf
article supplementary file uploaded. 28 March 2022 12:48 CEST - https://www.mdpi.com/2072-6694/14/7/1639#supplementary
article html file updated 28 March 2022 12:49 CEST Original file -
article html file updated 1 August 2022 07:16 CEST Update https://www.mdpi.com/2072-6694/14/7/1639/html
Back to TopTop